Stay updated on CMB305 in NY-ESO-1+ Cancer: Phase 1b Clinical Trial
Sign up to get notified when there's something new on the CMB305 in NY-ESO-1+ Cancer: Phase 1b Clinical Trial page.

Latest updates to the CMB305 in NY-ESO-1+ Cancer: Phase 1b Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe page now shows a 403 Forbidden error, replacing the expected study details with a minimal error page and a Home link. This indicates an access or load issue rather than the trial information.SummaryDifference19%

- Check18 days agoChange DetectedRevision label updated from v3.6.6 to v3.7.0, indicating a new software release for the page. This platform update does not modify the study details, eligibility criteria, or substantive content.SummaryDifference0.1%

- Check32 days agoChange DetectedRevision updated from v3.6.5 to v3.6.6 in the page history, indicating a small, non-substantive update to the page.SummaryDifference0.1%

- Check54 days agoChange DetectedFooter now shows Revision: v3.6.5, replacing the previous v3.6.4. This indicates a newer site build/version deployment without changes to page content.SummaryDifference0.1%

- Check75 days agoChange DetectedThe page's Revision tag was updated from v3.6.3 to v3.6.4, indicating a newer build or patch of the page.SummaryDifference0.1%

- Check97 days agoChange DetectedThe page's revision label was updated from v3.6.0 to v3.6.3, indicating a newer version of the study page. This is a metadata update and does not change the study content or how users interact with the page.SummaryDifference0.1%

Stay in the know with updates to CMB305 in NY-ESO-1+ Cancer: Phase 1b Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CMB305 in NY-ESO-1+ Cancer: Phase 1b Clinical Trial page.